Author:
Kgatle Mankgopo Magdeline,Lawal Ismaheel Opeyemi,Mashabela Gabriel,Boshomane Tebatso Moshoeu Gillian,Koatale Palesa Caroline,Mahasha Phetole Walter,Ndlovu Honest,Vorster Mariza,Rodrigues Hosana Gomes,Zeevaart Jan Rijn,Gordon Siamon,Moura-Alves Pedro,Sathekge Mike Machaba
Abstract
The progression of coronavirus disease 2019 (COVID-19), resulting from a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, may be influenced by both genetic and environmental factors. Several viruses hijack the host genome machinery for their own advantage and survival, and similar phenomena might occur upon SARS-CoV-2 infection. Severe cases of COVID-19 may be driven by metabolic and epigenetic driven mechanisms, including DNA methylation and histone/chromatin alterations. These epigenetic phenomena may respond to enhanced viral replication and mediate persistent long-term infection and clinical phenotypes associated with severe COVID-19 cases and fatalities. Understanding the epigenetic events involved, and their clinical significance, may provide novel insights valuable for the therapeutic control and management of the COVID-19 pandemic. This review highlights different epigenetic marks potentially associated with COVID-19 development, clinical manifestation, and progression.
Subject
Immunology,Immunology and Allergy
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献